ZoomInfo Technologies Inc. (GTM) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy
Forensic Analysis · Technology / Software · as of Jul 13, 2026
ZoomInfo Technologies Inc. (GTM)
A forensic read on ZoomInfo Technologies Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Distress
Financial health
0.6
Altman Z-score
Clean
Earnings quality
3
Forensic signals
6.8
P / E (ttm)
6.5%
ROE
$908M
Market cap
ZoomInfo Technologies Inc. earns a D (Weak — demands caution) forensic quality grade, and its Altman Z-score is 0.6, placing it in the Distress zone. 3 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
3%Return on invested capital.Return on invested capital is 3% in the latest fiscal year and steady — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
9% of revStock-based comp load.Stock-based compensation ran 9% of revenue and 30% of free cash flow in FY2025 — about $0.36 per diluted share. Meaningful — reported free cash flow flatters the economics, since SBC is a real cost paid in shares.
106% of FCFShareholder returns.Returned $411M to shareholders (buybacks + dividends) in FY2025 — 106% of free cash flow. Right at the limit of what free cash flow covers — little room before it's funded by debt or the balance sheet. That ratio has been CLIMBING toward the limit — 0% of free cash flow a few years back — not just sitting there.
Key fundamentals
Net Margin9.9%
Debt / Equity0.88x
Free Cash Flow$375.5M
Latest Revenue$1.25B
Return on Equity8.2%
Revenue CAGR (3yr)+4.4%
Revenue Growth YoY+2.9%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on ZoomInfo Technologies Inc.:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about GTM's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown